Field IIT requests by focusing on your launch and portfolio strategy with data to support your decisions
CHAPEL HILL, N.C., Aug. 21, 2021/PRNewswire/ -- The careful selection of IITs can be an important link in the chain of new product launch and portfolio management. However, choosing studies which can be properly leveraged to drive the success of launches can be daunting considering shifting launch plans and corporate objectives. How are IIT management strategies being implemented to deliver the best results?
https://www.best-in-class.com/rw80.htm">“Best Practices in the Oversight and Management of Investigator Initiated Trials in CNS Therapeutic Area” is a new 62-page study that provides a detailed roadmap for improving IIT management within CNS companies, capturing critical metrics and insights on IIT management team staffing, budget, and communication.
Topics addressed in this research include:
- IIT Submission Review and Systems
- Functional Involvement
- IIT Funding
- Future Improvements
- Important Criteria for IIT Evaluation
- Key Reasons for Rejecting IIT Proposals
The study engaged 17 leaders from 13 bio-pharmaceutical companies offering CNS products. Nearly 90% of the benchmark partners serve at the director level or above.
Key insights from the report highlight the most important criteria when evaluating an IIT proposal:
- Strategic value (75% rated this criterion as “highly important”)
- Strategic fit (58% rated this criterion as “highly important”)
- Relevance of potential results (42% rated this criterion as “highly important”)
For more data regarding CNS IIT Management, download the complimentary summary here: https://www.best-in-class.com/rw80.htm">https://www.best-in-class.com/rw80.htm
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.